The importance of a regulatory science approach for better pharmaceutical regulation

DOI Web Site 被引用文献1件 参考文献10件
  • Uyama Yoshiaki
    Office of Medical Informatics and Epidmeiology, Pharmaceuticals & Medical Devices Agency (PMDA), Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan

抄録

<p> Although regulatory science has been recognized as an important field in the area of pharmaceutical regulation, it may be still immature and is likely to evolve further as science itself advances with an increasing accumulation of knowledge and experience. In real-life situations, the strength of evidence for each set of data and information used for regulatory assessment varies widely. Indeed, inconsistent results are not uncommon. Scientific, non-biased, and objective assessment based on all of the available data and information may pinpoint the truth and determine the value of science to society in advancing public health. From this perspective, regulatory science can be viewed as important for finding practical and up-to-date solutions for issues where there is a degree of scientific uncertainty and limitations. As such, regulatory science is invaluable for improving pharmaceutical regulation. The combined involvement of experts across a wide range of disciplines engaged in medical, pharmaceutical, statistical and technological sciences, as well as economics, jurisprudence, education, and other disciplines will be important in increasing research activities in regulatory science. Discussing each issue from various perspectives will be crucial in finding the best solutions. Continuous effort at the global level will be necessary for further developments of "regulatory science" that can be applied to various real-life issues in society.</p>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (10)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ